L. DelCarpio-Orantes, Ponce-Morfín Af, Juárez-Rangel Fj
{"title":"间充质干细胞治疗重症COVID-19","authors":"L. DelCarpio-Orantes, Ponce-Morfín Af, Juárez-Rangel Fj","doi":"10.15761/jscrm.1000143","DOIUrl":null,"url":null,"abstract":"Current regenerative medicine is based on the use of mesenchymal stem cells through which regenerative and immunomodulatory properties have been seen. In this last respect, it has been hypothesized that the use of mesenchymal stem cells in severe acute inflammatory conditions such as those seen in cases of Sars Cov2 infection may benefit from the use of this therapy due to the anti-inflammatory, immunomodulatory, regenerative properties coupled with These cells do not express the ACE2 receptor, which gives them resistance to the virus.","PeriodicalId":318869,"journal":{"name":"Journal of Stem Cell Research and Medicine","volume":"117 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Mesenchymal stem cells for the treatment of severe COVID-19\",\"authors\":\"L. DelCarpio-Orantes, Ponce-Morfín Af, Juárez-Rangel Fj\",\"doi\":\"10.15761/jscrm.1000143\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Current regenerative medicine is based on the use of mesenchymal stem cells through which regenerative and immunomodulatory properties have been seen. In this last respect, it has been hypothesized that the use of mesenchymal stem cells in severe acute inflammatory conditions such as those seen in cases of Sars Cov2 infection may benefit from the use of this therapy due to the anti-inflammatory, immunomodulatory, regenerative properties coupled with These cells do not express the ACE2 receptor, which gives them resistance to the virus.\",\"PeriodicalId\":318869,\"journal\":{\"name\":\"Journal of Stem Cell Research and Medicine\",\"volume\":\"117 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Stem Cell Research and Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15761/jscrm.1000143\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Stem Cell Research and Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15761/jscrm.1000143","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Mesenchymal stem cells for the treatment of severe COVID-19
Current regenerative medicine is based on the use of mesenchymal stem cells through which regenerative and immunomodulatory properties have been seen. In this last respect, it has been hypothesized that the use of mesenchymal stem cells in severe acute inflammatory conditions such as those seen in cases of Sars Cov2 infection may benefit from the use of this therapy due to the anti-inflammatory, immunomodulatory, regenerative properties coupled with These cells do not express the ACE2 receptor, which gives them resistance to the virus.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
